(Q84574318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Robert W Holloway

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

19 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

147-8; author reply 149-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Breast cancer survival and in vitro tumor response in the extreme drug resistance assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Extreme drug resistance in primary brain tumors: in vitro analysis of 64 resection specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.027

10.1016/J.YGYNO.2009.08.027

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19767066%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference